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ABSTRACT
Background: The establishment of minor eye
conditions schemes (MECS) within community
optometric practices provides a mechanism for the
timely assessment of patients presenting with a range
of acute eye conditions. This has the potential to
reduce waiting times and avoid unnecessary referrals
to hospital eye services (HES).
Objective: To evaluate the clinical effectiveness,
impact on hospital attendances and patient satisfaction
with a minor eye service provided by community
optometrists.
Methods: Activity and outcome data were collected for
12 months in the Lambeth and Lewisham MECS. A
patient satisfaction questionnaire was given to patients
at the end of their MECS appointment. A retrospective
difference-in-differences analysis of hospital activity
compared changes in the volume of referrals by general
practitioners (GPs) from a period before (April 2011–
March 2013) to after (April 2013–March 2015) the
introduction of the scheme in Lambeth and Lewisham
relative to a neighbouring area (Southwark) where the
scheme had not been commissioned. Appropriateness
of case management was assessed by consensus using
clinical members of the research team.
Results: A total of 2123 patients accessed the scheme.
Approximately two-thirds of patients (67.5%) were
referred by their GP. The commonest reasons for
patients attending for a MECS assessment were ‘red
eye’ (36.7% of patients), ‘painful white eye’ (11.1%) and
‘flashes and floaters’ (10.2%). A total of 64.1% of
patients were managed in optometric practice and
18.9% were referred to the HES; of these, 89.2% had
been appropriately referred. First attendances to HES
referred by GPs reduced by 26.8% (95% CI −40.5% to
−13.1%) in Lambeth and Lewisham compared to
Southwark.
Conclusions: The Lambeth and Lewisham MECS
demonstrates clinical effectiveness, reduction in
hospital attendances and high patient satisfaction and
represents a successful collaboration between
commissioners, local HES units and primary healthcare
providers.
INTRODUCTION
The National Health Service (NHS) General
Ophthalmic Services (GOS) provides for
routine sight testing across the UK through
community optometry. In parallel to the
availability of GOS, a number of enhanced
service schemes (ESS) (also known as
Community Eyecare Schemes) are currently
delivered by optometrists. ESS have evolved
over the past decade, following an amend-
ment to the General Optical Council ‘Rules
relating to injury or disease of the eye’,
which removed the obligation to refer
patients with a disease or abnormality of the
eye to medical practitioners, if there is no
justiﬁcation to do so.1 Optometrists can also
refer patients to another optometrist instead
of a medical practitioner. These changes
enabled many community optometrists to
participate in ESS, furthering their profes-
sional development and building better rela-
tionships with the hospital eye service
(HES).2
Ophthalmology represents the eighth
highest level of programme spend in
Strengths and limitations of this study
▪ A case study approach lends itself to in-depth
complex health service research and can yield
powerful insights into aspects of health and
healthcare delivery.
▪ The Lambeth and Lewisham minor eye condi-
tions scheme is one of the first enhanced service
schemes to be comprehensively evaluated.
▪ Equivalent data were also obtained for a neigh-
bouring commissioning area (Southwark) in
which the scheme was not introduced, allowing
a comparison between hospital eye service
(HES) referrals in areas with and without the
scheme.
▪ The appropriateness of the management of
patients seen under the scheme was assessed
by a consensus panel from the study team, and
for patients referred to the HES by two
ophthalmologists.
▪ The findings are not necessarily generalisable to
other areas of the UK.
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England3 and accounts for 9% of all NHS outpatient
attendances.4 The key potential beneﬁts from ESS are
saving HES resources, shorter waiting times for patients
and patient convenience.5 Over the past decade, special-
ist ophthalmic Accident and Emergency (A&E) depart-
ments have reported that ∼30% of patients presenting
to A&E have non-emergency conditions that could be
managed in the community.6 7 A recently introduced
type of ESS is a minor eye conditions scheme (MECS),
which aims to reduce A&E and GP workloads. A
number of MECS have been launched across the UK
and have demonstrated clinical safety, reduced HES
referrals, high patient satisfaction and GP trust.8–12
However, there is limited evidence on the cost-
effectiveness of such schemes; the Primary Eyecare
Acute Referral Scheme (PEARS) in Wales has shown evi-
dence of cost-effectiveness,11 but other schemes have
not been evaluated.
The aim of this mixed methods case study was to
determine the clinical effectiveness and impact on hos-
pital attendances of the Lambeth and Lewisham MECS
and to investigate patient satisfaction. MECS is an NHS
funded service developed by Lewisham and Lambeth
Clinical Commissioning Groups (CCGs) to target those
A&E referrals that could be managed in the community.
The scheme represents a collaboration between a
number of ophthalmic care providers in the boroughs;
ophthalmologists from Guy’s and St Thomas’ Hospital
and King’s College Hospital, community optometrists,
GPs and the local CCGs were all involved in designing
and maintaining the scheme.
METHODS
Scheme organisation
The scheme was launched in April 2013 as a 2-year pilot
study with a 1-year extension and 10 optometrists
working in 13 community optometric practices partici-
pated. A map of the participating practices is shown in
ﬁgure 1.
Optometrists were trained and accredited using distance
learning modules provided by the Local Optometric
Committee Support Unit and the Welsh Optometric
Postgraduate Education Centre. Optometrists were also
required to pass a practical station assessment, but a spe-
cialist prescribing qualiﬁcation was not required, although
certain medications could be supplied using the Entry
Level Medicines Act exemptions.13 Optometrists also
observed HES clinics and maintained a scheduled contact
with consultant ophthalmologists at King’s College
Hospital or Guy’s and St Thomas’ Hospital, receiving feed-
back on their referrals. Participating optometrists were
remunerated by the local CCG.
Two ophthalmologists from the collaborating HES also
participated in the MECS. Each ophthalmologist had
one session per week allocated to MECS as part of the
pilot scheme, to review clinical records of patients seen
through the scheme and review the outcome of all
referrals to the HES. They also provided mentoring
support and continuing education to participating
optometrists.
Patients who presented to their GP with eye problems
and satisﬁed certain inclusion criteria were referred to
accredited MECS optometrists. The scheme was pro-
moted to local GPs at a regional educational GP event.
Patients could also refer themselves to MECS optome-
trists. Inclusion criteria encompassed red eye, loss of
vision, trauma, headaches, painful white eye, and ﬂashes
and ﬂoaters. Patients were examined by optometrists
within 48 hours and could be either managed within
community optometric practice or referred directly to
the HES. Patients could also be referred to their GP for
systemic investigations.
Scheme monitoring—clinical effectiveness
Scheme activity was closely monitored by the research
team for 12 months from September 2013 to August
2014. Patients provided informed consent for their
anonymised clinical data to be collected. Details of each
MECS examination were entered on an electronic
record by participating optometrists and uploaded onto
a secure NHS server; key data were extracted and
entered onto a password-protected database. The follow-
ing data were extracted from clinical records: patients’
age, ﬁrst part of postcode, ethnicity, GP details, present-
ing symptom, vision and/or visual acuity, diagnosis, man-
agement and, where applicable, the HES to which
referral was made, the urgency of referral and the HES
diagnosis. The International Classiﬁcation of Diseases
codes published by the WHO were used for recording
the diagnosis in community practice and/or the HES.14
To assess the clinical safety of MECS, a randomly
selected sample of 220 MECS clinical records stratiﬁed
by participating optometry practice were reviewed and
independently graded by the four optometrist members
of the research team ( JGL, DFE, RAH and EK). Clinical
management was categorised as appropriate or inappro-
priate. In addition, referrals to both of the collaborating
HES were assessed by the ophthalmologist members of
the team (SJ and GL). Each diagnosis by HES clinicians
was made available and these were cross-referenced with
MECS community optometrists’ diagnoses. The ophthal-
mologists made a judgement on the appropriateness of
referrals made by optometrists and the appropriateness
of referral urgency.
Impact on hospital attendances
Administrative data describing the volume of patients
being referred via MECS between 1 September 2013
and 30 August 2014 were obtained, as well as counts of
ﬁrst and follow-up outpatient attendances to the HES.
The data were obtained for the ﬁnancial years 2011/
2012–2014/2015 from Hospital Episode Statistics.
Equivalent data were also obtained for a neighbouring
commissioning area (Southwark) in which the scheme
was not introduced. The difference-in-differences (DiD)
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estimator was used to compare baseline data from 2011–
2012 and 2012–2013 to data after the introduction of
the scheme in 2013–2014 and 2014–2015. The DiD is
the change over time in the number of attendances in
the areas the scheme was operating minus the change
over time in the number of attendances in the compari-
son areas. Linear regression was used, including binary
variables for each quarter to control for time trends and
binary variables for each hospital to control for differ-
ences between providers.
Patient satisfaction
A patient satisfaction questionnaire was given to patients
at the end of their MECS appointment. Patients were
asked to complete the questionnaire and return it to the
independent research team using a prepaid envelope.
The questionnaire consisted of nine multiple choice
questions and one open-ended question, addressing
levels of patient satisfaction from their point of entry
into MECS. Questionnaires were distributed during
August 2014 and September 2014.
Statistical analysis
SPSS software (IBM Corp. Released 2013. IBM SPSS
Statistics for Windows, V.22.0. Armonk, New York, USA:
IBM Corp) and Stata (StataCorp 2013. Stata Statistical
Software: Release 13. College Station, Texas, USA:
StataCorp LP) were used for statistical analysis. Pearson’s
correlation coefﬁcient was used to investigate correla-
tions and the two-proportion z-test to compare differ-
ences between proportions. p<0.05 was taken to be
statistically signiﬁcant for all tests.
RESULTS
Demographics and scheme activity
The scheme was monitored for 12 months, during which
2307 patient visits to MECS optometrists took place, with
2123 patients assessed at 13 community practices. The
youngest patient seen through MECS was 1 year and the
oldest was 93 years (median age: 47 years, IQR: 33–
62 years); no data on patient gender were available. The
scheme was accessed by people from a range of ethnic
groups (table 1), although 39.9% of patients who
accessed the scheme did not reveal their ethnicity.
The average number of patient episodes per month
was 188 (range: 108–258); there was no signiﬁcant cor-
relation between the length of time the scheme had
been running and the monthly volume of patients seen
(R2=0.23, p=0.1). Patient volume varied signiﬁcantly
between practices (p<0.001); the maximum number of
Figure 1 Map of the community optometric practices participating in the Lambeth and Lewisham MECS.
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MECS patients seen by any practice in the 12-month
study period was 483 and the minimum was 21; two prac-
tices accounted for 39.2% of all MECS patients, while
one practice (practice 12) closed 7 months after the
scheme started.
Approximately two-thirds of patients (67.5%) were
referred by their GP (range of GP referrals between
practices: 37.1–91.6%); a total of 118 GP practices
referred patients to MECS (range of referred patients:
1–83 per GP practice, not adjusted to practice list size).
Approximately 78% of GP practices registered in
Lambeth CCG and ∼90% of practices registered in
Lewisham CCG referred patients to MECS. A total of
26.8% of patients who used MECS were self-referred,
2.2% were referred by a pharmacist and 3.4% were
patients who presented to the optometrist for a sight
test, which was subsequently converted to an MECS
appointment. There was no signiﬁcant correlation
between the length of time the scheme had been
running and the referral source (GP referrals: R2=0.25,
p=0.1; self-referrals: R2=0.01, p=0.8).
The commonest reason for an MECS assessment was
‘red eye’ (36.7% of patients); ‘painful white eye’ (11.1%),
‘ﬂashes and ﬂoaters’ (10.2%) and ‘loss of vision’ (9.2%)
were other common reasons for attending, while ‘head-
aches’ (5.3%), ‘trauma’ (1.7%) and ‘diplopia’ (0.4%)
were less common. A quarter (25.4%) of patients seen
through MECS presented for reasons that did not fall
under any of the predeﬁned criteria; two-thirds of these
(66.2%) presented with anterior eye symptoms (eg, dry
or watery eyes, lid lumps and foreign body sensation).
Patient management and clinical safety
Of the patients seen through MECS, 75.3% were retained
in community practice, 64.1% were managed by commu-
nity optometrists and 11.2% discharged with no ocular
pathology identiﬁed. A total of 5.7% were referred to their
GP. In total, 18.9% of the patients were referred to the
HES (table 2); of these, 49.1% were referred routinely,
22.6% urgently and 28.3% as an emergency.
Of those patients initially managed in practice, 8.7%
returned to MECS, either because the optometrist asked
them to return or because their problem had not
resolved; of those, 61.4% were managed in practice,
19.0% were discharged with their pathology resolved,
13.0% were referred to HES and 6.0% were referred to
their GP. Practices varied signiﬁcantly in terms of the
proportion of patients who returned for a follow-up
appointment (range: 2.0–15.9%, p<0.001).
A topical or oral medication was supplied to 48.3% of
MECS patients. Ocular lubricants were the most com-
monly supplied topical medication (29.7% of all patients
seen through MECS), followed by local antibiotic drops
(ie, chloramphenicol or fusidic acid, 12.1%), topical
and systemic antiallergy agents (6.1%) and systemic anal-
gesia (0.5%).
Referral rates varied signiﬁcantly by practice and
ranged from 5.2% to 30.8% (ﬁrst visits only, p<0.001) of
patients seen through each practice. There was no signiﬁ-
cant correlation between the source of referrals into
MECS and onward HES referral rates (p=0.36, R2=0.07).
There was no obvious difference in case mix between
practices.
Based on a consensus panel of team members, an
∼10% (220/2123) stratiﬁed random sample of patients
seen within the scheme was assessed and 95% (208/220)
of these patients were deemed to be appropriately
managed. Of the remaining 12 patients, the panel classi-
ﬁed four as inappropriate prescribing (three for unneces-
sary topical antibiotics), four as unnecessary referrals, two
as referrals with greater urgency than required and two as
inappropriate management (one where pupil dilation
was not carried out and one where intraocular pressure
had not been recorded). However, there were no major
clinical safety issues arising from this evaluation. Data
were available for 72.0% of the HES referrals. Of these,
89.2% were judged to have been appropriately referred
and 78.2% were referred with appropriate urgency. In
the case of HES referrals where urgency was classiﬁed as
inappropriate, in over 90% of cases these were referred
with greater urgency than required.
Impact on hospital attendances
First attendances to hospital ophthalmology referred by
GPs dropped by 26.8% (95% CI −40.5 to −13.1) more
Table 1 Ethnicities of the patients who accessed the
Lambeth and Lewisham MECS
Ethnicity % of patients
Not stated 39.9
British/Mixed British 23.8
Other white background 9.6
African 8.9
Caribbean 8.1
Other black background 1.9
Other ethnic category 1.9
Other Asian background 1.6
Indian/British Indian 1.0
Other stated ethnicities 3.1
MECS, minor eye conditions scheme.






Management of ocular pathology in practice 64.1 (1359)
Discharge/no ocular pathology detected 11.2 (236)
Referral to King’s College Hospital 10.4 (220)
Referral to Guy’s and St Thomas’ Hospital 7.3 (154)
Referral to other HES 1.2 (26)
Referral to GP 5.7 (122)
GP, general practitioner; HES, hospital eye services; MECS,
minor eye conditions scheme.
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in the areas operating the MECS compared to the com-
parison area. Follow-up appointments at hospital oph-
thalmology (initially referred from GP) fell by 12.9%
(95% CI −20.2% to −5.6%) in the areas operating the
MECS scheme compared to the comparison area
(Southwark).
Patient satisfaction
There were 109 responses to the questionnaire (∼28%
response rate). All patients (100%) who completed the
survey were satisﬁed with their visit to the optometrist
and 99% would recommend the scheme to a friend;
95% of the patients reported conﬁdence and trust in
their MECS optometrist and 90% were satisﬁed with the
location of the practices they attended.
DISCUSSION
The Lambeth and Lewisham MECS was designed to
reduce ophthalmology referrals for two London bor-
oughs, after an audit by Lambeth CCG indicated that
∼38% of acute ophthalmology referrals could have been
managed by either community optometrists or GPs.15
This study monitored the pilot Lambeth and Lewisham
MECS for 12 months, starting retrieval of patient
records 6 months after the scheme’s launch. A strong
clinical governance framework exists around this
scheme: structured training is required for optometrists’
participation, who have access to thorough clinical man-
agement guidelines provided by the College of
Optometrists;16 the scheme is being audited by local
CCGs and collaborating hospitals and is monitored by
the Eye Group, comprising commissioners, GPs,
ophthalmologists and optometrists, who meet on a
regular basis. Results suggest that the Lambeth and
Lewisham MECS reduces HES referrals relative to a
neighbouring area (Southwark) where the scheme had
not been commissioned, while ensuring appropriate
HES referrals, patient safety and patient satisfaction.
The scheme was accessible to all ethnic groups resid-
ing in the two boroughs, and the ethnic distribution of
patients in MECS was similar to the ethnicity distribution
in Lambeth and Lewisham as a whole17 18 over a
12-month period. The evaluated scheme provided oph-
thalmic care to 2123 patients, with a higher average
number of patients per practice compared to the Welsh
PEARS and other MECS schemes previously evaluated in
England.8 10 12 There was signiﬁcant variation in
numbers of patients seen per practice; two practices
accounted for ∼40% of all patients seen through MECS,
whereas one practice saw only 20 patients during
12 months of monitoring. Similar variability in the
number of patients seen by practices in ESS has been
reported previously.9 The freedom of patients to self-
refer, and GPs to refer to a practice of their choice, may
lead them to choose speciﬁc practices by virtue of loca-
tion, ease of access and/or reputation.
In this study, 67.5% of patients accessing MECS were
referred from their GP, with marked variability in
numbers of GP referrals between practices. Patient self-
referral into MECS was less common and stable through-
out the pilot scheme, suggesting that patients’
healthcare-seeking behaviour favoured contacting the
GP initially; this trend remained unchanged despite
local advertising of the scheme. Signiﬁcant GP engage-
ment in the scheme contributed to its success. Previous
results on the experience and views of GPs on eye-
related problems suggest that GPs may lack conﬁdence
in managing eye problems19 and may favour assessment
of patients by optometrists, which will improve the
patients’ journey, provide patients with more choices
and help GPs in hard to diagnose cases (eg, red eyes
and/or ﬂashes and ﬂoaters).2 20
Patients accessed the scheme with a variety of present-
ing symptoms; red or painful eye, loss of vision and
ﬂashes and ﬂoaters (patients who might be at risk of a
retinal detachment) were the most common. These pre-
senting symptoms represent the commonest reasons for
attendance in similar schemes, which commonly corres-
pond to pathologies judged to be manageable by com-
munity services.6 A total of 82.3% (n=1747) of patients
(ﬁrst and follow-up visits) were retained in community
optometric practices (either managed by community
optometrists or discharged), compared to 66% of
patients who accessed the Wales PEARS11 or other
smaller schemes.10 12
A total of 8.7% of patients returned to community
optometric practice for a follow-up appointment. The
average follow-up rate in similar ESS has been reported
to be 22.13%,8 with individual schemes reporting rates
between 6.3% and 56.3%;8–10 12 21 no data are available
for the PEARS in Wales.11 HES referral rates for UK
MECS schemes have been reported to average 19.3%;8
18.2% of patients accessing the PEARS were referred to
the HES, a rate similar to the Lambeth and Lewisham
MECS (18.9%). Referral rates to GPs in the Lambeth
and Lewisham MECS (5.7%) were below the reported
UK average for similar schemes (8.63%)8 and lower
than the PEARS (16%).11
There was signiﬁcant variability between practices in
the proportion of follow-up visits and referral rates
observed in this scheme. This variability may be related
to the nature of the scheme; the Lambeth and Lewisham
MECS lacks a speciﬁc protocol outlining referral or
follow-up criteria for the various pathologies. Community
optometrists were trained and attended A&E sessions at
their local HES, while maintaining a scheduled contact
with participating consultant ophthalmologists, receiving
feedback on referrals. Participating optometrists prac-
ticed according to College of Optometrists’ Clinical
Management Guidelines16 and could exercise clinical
judgement. It could be argued that a detailed protocol
might reduce referral variability between practices.
Previous qualitative research on motivation for participa-
tion in this scheme has, however, indicated that ‘[…]
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participation in ESS would allow them (optometrists) to
be exposed to more challenging clinical cases and conse-
quently have opportunities to use their clinical skills to a
greater extent’.2 To attract community optometrists, ESS
must maintain optometrists’ interest and enhance clinical
and decision-making skills, while providing patients with
a safe service.
Although the optometrists participating in the
Lambeth and Lewisham MECS did not have a non-
medical prescribing qualiﬁcation, medication was sup-
plied to 48.3% of ﬁrst and follow-up visits; patients were
referred to secondary care due to the seriousness of
their condition and not as a result of a lack of prescrib-
ing rights, as might be the case elsewhere.21
Approximately a quarter of patients who needed a pre-
scription were prescribed antibiotic drops, with ocular
lubricants being the predominantly prescribed ocular
medication. It has been reported that GPs may overpre-
scribe ocular antibiotics, due to a number of factors,
with patient pressure or inability to discriminate
between viral and bacterial conjunctivitis being common
reasons.22–24 The ophthalmic expertise of GPs and lack
of availability of specialised equipment, as well as the
need for further ophthalmic training, is still under
debate;6 25 the current ﬁndings indicate that optome-
trists are in a good position to differentiate between
various ocular pathologies, prescribing appropriate
medication.
Ninety-ﬁve per cent of patients seen within the
scheme were assessed as being appropriately managed
and there were no major clinical safety concerns in
those inappropriately managed. Approximately 11% of
referrals were judged unnecessary by ophthalmologists
who monitored the scheme, compared to 17.7%
reported in the PEARS.11 Referrals were generally sent
with an appropriate degree of urgency. Of those judged
to be inappropriate, over 90% were sent with greater
urgency than considered necessary. These ﬁndings indi-
cate a safe service, despite some differences of opinion
between optometrists and ophthalmologists regarding
referral urgency.
Ophthalmologists collaboration has been crucial for
the development of this pilot ESS, providing mentor-
ing to community optometrists and feedback on refer-
ral safety. A similar involvement in future schemes
cannot be guaranteed, due to ﬁnancial and time con-
straints. Equally, generalisability of such schemes is not
guaranteed for other UK areas where similar schemes
might be introduced, despite their success in Wales
and South London. This study did not follow the prin-
ciples of randomised controlled trials, since an obser-
vational pragmatic evaluation is more suitable for
community healthcare services research.26 Future eva-
luations could follow a stepped wedge or interrupted
time series design; the latter was not possible in this
study, due to a lack of historical data on referrals.
The Lambeth and Lewisham MECS is one of the ﬁrst
ESS to be comprehensively evaluated; results suggest
that the scheme is safe for patients, while providing a
service that also beneﬁts the NHS. Collaboration
between eye care providers has promoted the scheme’s
popularity and increased its chances of sustainability.
Appropriate training, support by local CCGs and
ongoing collaboration between eye care providers are
necessary to design and operate safe and successful ESS
that reduce hospital attendances.
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